Clinical and Prognostic Impact of Copy Number Alterations and Associated Risk Profiles in a Cohort of Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Cases Treated Under ICiCLe Protocol.


Journal

HemaSphere
ISSN: 2572-9241
Titre abrégé: Hemasphere
Pays: United States
ID NLM: 101740619

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 29 06 2022
accepted: 26 08 2022
entrez: 7 10 2022
pubmed: 8 10 2022
medline: 8 10 2022
Statut: epublish

Résumé

Copy number alteration (CNA) status and CNA risk profiles of

Identifiants

pubmed: 36204689
doi: 10.1097/HS9.0000000000000782
pmc: PMC9529051
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e782

Informations de copyright

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

Références

Blood Adv. 2021 Sep 14;5(17):3322-3332
pubmed: 34477813
Leukemia. 2015 Nov;29(11):2154-61
pubmed: 26050650
Blood. 2000 Oct 15;96(8):2691-6
pubmed: 11023499
J Clin Oncol. 2018 Apr 20;36(12):1240-1249
pubmed: 29498923
Lancet. 2011 Feb 19;377(9766):618-9
pubmed: 21227498
Blood. 2009 Sep 3;114(10):2159-67
pubmed: 19589926
Pediatr Blood Cancer. 2008 Nov;51(5):621-5
pubmed: 18688848
J Clin Oncol. 2009 Nov 1;27(31):5202-7
pubmed: 19770381
Cancers (Basel). 2021 Jun 30;13(13):
pubmed: 34209196
Leuk Res. 2021 Dec;111:106683
pubmed: 34371436
Am J Hematol. 1983 Aug;15(1):35-43
pubmed: 6576629
Pediatr Blood Cancer. 2018 Jun;65(6):e27001
pubmed: 29446543
Semin Hematol. 2013 Jul;50(3):185-96
pubmed: 23953334
Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e666-e673
pubmed: 33906825
Hematol Oncol. 2022 Aug;40(3):430-441
pubmed: 35118711
JAMA Oncol. 2021 Oct 01;7(10):1521-1528
pubmed: 34410295
Ann Hematol. 2021 Oct;100(10):2487-2500
pubmed: 34236495
Eur J Cancer. 2005 Jul;41(11):1570-83
pubmed: 16026693
Haematologica. 2013 Jul;98(7):1081-8
pubmed: 23508010
South Asian J Cancer. 2016 Jul-Sep;5(3):155-60
pubmed: 27606304
Leukemia. 2022 Mar;36(3):625-636
pubmed: 34657128
Indian J Med Paediatr Oncol. 2015 Oct-Dec;36(4):261-4
pubmed: 26811597
Leuk Res. 2018 Mar;66:79-84
pubmed: 29407587
Br J Haematol. 2015 Sep;170(6):847-58
pubmed: 26018335
Leuk Lymphoma. 2017 Feb;58(2):333-342
pubmed: 27339065
Leukemia. 2010 Jul;24(7):1258-64
pubmed: 20445578
Haematologica. 2013 Mar;98(3):428-32
pubmed: 22875627
Leuk Lymphoma. 2019 Feb;60(2):433-441
pubmed: 29966470
Blood Adv. 2019 Jan 22;3(2):148-157
pubmed: 30651283
Pediatr Blood Cancer. 2017 Apr;64(4):
pubmed: 27762058
Blood. 2016 Aug 18;128(7):911-22
pubmed: 27229005
Haematologica. 2017 Mar;102(3):541-551
pubmed: 27979924
N Engl J Med. 2009 Jan 29;360(5):470-80
pubmed: 19129520
Cancer. 2015 Nov 1;121(21):3809-17
pubmed: 26194343
Blood. 2014 Aug 28;124(9):1434-44
pubmed: 24957142
Haematologica. 2022 Sep 01;107(9):2051-2063
pubmed: 34788984
N Engl J Med. 2014 Sep 11;371(11):1005-15
pubmed: 25207766
Cancer Epidemiol. 2021 Apr;71(Pt B):101679
pubmed: 32033883

Auteurs

Sanjeev Kumar Gupta (SK)

Laboratory Oncology Unit, BRA Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Minu Singh (M)

Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Pragna H Chandrashekar (PH)

Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Sameer Bakhshi (S)

Department of Medical Oncology, BRA Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Amita Trehan (A)

Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Ritu Gupta (R)

Laboratory Oncology Unit, BRA Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Rozy Thakur (R)

Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Smeeta Gajendra (S)

Laboratory Oncology Unit, BRA Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Preity Sharma (P)

Laboratory Oncology Unit, BRA Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Sreejesh Sreedharanunni (S)

Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Manupdesh S Sachdeva (MS)

Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Deepam Pushpam (D)

Department of Medical Oncology, BRA Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Neelam Varma (N)

Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Deepak Bansal (D)

Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Richa Jain (R)

Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Srinivasan Peyam (S)

Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Anthony V Moorman (AV)

Leukaemia Research Cytogenetics Group, Newcastle University Clinical and Translational Research Institute, United Kingdom.

Prateek Bhatia (P)

Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Classifications MeSH